Skip to main content
. 2017 Apr 1;2(1):72–80. doi: 10.1089/can.2016.0035

FIG. 1.

FIG. 1.

The different implications of ECS in endometriosis and pain. High levels of CB1 receptors and endocannabinoid ligands have been observed in endometriosis patients. Although this occurs as a mechanism to reduce inflammation, low CB1 levels in the tissue act as a negative feedback loop and disrupt the pain mechanism. However, several natural and synthetic agonists modulate ECS and reduce endometriosis-associated pain. ECS, endocannabinoid system; PEA, N-palmitoylethanolamine.